Pharma · Private company
Menarini Group
Track this companyFree. Adds Menarini Group to your Dealase workspace and tells you when its record changes.
Clinical trials51 recruiting or active
Pipeline programs7From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline7
- CetuximabPhase 2 · Metastatic Colorectal CancerClinicalTrials.gov · fetched Nov 12, 2026
- MEN1611Phase 2 · Metastatic Colorectal CancerClinicalTrials.gov · fetched Nov 12, 2026
- MEN1703Phase 2 · Acute Myeloid LeukemiaClinicalTrials.gov · fetched Nov 12, 2026
- NepadutantPhase 2 · ColicClinicalTrials.gov · fetched Nov 12, 2026
- FulvestrantPhase 1 · Advanced or Metastatic Breast CancerClinicalTrials.gov · fetched Nov 12, 2026
- MEN1611Phase 1 · Advanced or Metastatic Breast CancerClinicalTrials.gov · fetched Nov 12, 2026
- TrastuzumabPhase 1 · Advanced or Metastatic Breast CancerClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials5
- PhII Randomized CAPecitabine + ELAcestrant vs. Capecitabine Alone in ER+ Breast Cancer (CAPELA)PHASE2 · RECRUITING · started Jan 16, 2026ClinicalTrials.gov NCT07222215 · fetched Nov 12, 2026
- MEN1611 With Cetuximab in Metastatic Colorectal Cancer (C-PRECISE-01)PHASE1_PHASE2 · COMPLETED · started Jul 20, 2020ClinicalTrials.gov NCT04495621 · fetched Nov 12, 2026
- MEN1611 With Trastuzumab (+/- Fulvestrant) in Metastatic Breast CancerPHASE1 · COMPLETED · started Nov 13, 2018ClinicalTrials.gov NCT03767335 · fetched Nov 12, 2026
- MEN1703 (SEL24) in Participants With Acute Myeloid LeukemiaPHASE1_PHASE2 · COMPLETED · started Mar 10, 2017ClinicalTrials.gov NCT03008187 · fetched Nov 12, 2026
- Preliminary Efficacy, Safety and Pharmacokinetics Study of Nepadutant in Infant With Feeding IntolerancePHASE2 · COMPLETED · started Aug 1, 2011ClinicalTrials.gov NCT01532518 · fetched Nov 12, 2026